Floatz logo

DESFERRIOXAMINE B

Hemosiderosis

Ain Shams UniversitySmall moleculePhase 4 / ApprovedDormant
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
59/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hemosiderosis cohort.

Asset / SponsorPhaseRating
Deferasirox
Shire
Phase 4A
Deferiprone
Ain Shams University
Phase 4BB
Ferriprox
Ain Shams University
Phase 2/3B
Deferitazole
Shire
Phase 2CCC

Same molecule, other indications

DESFERRIOXAMINE B is also rated in:

beta-thalassemia majorActive
BBB
Indicative · Phase 4
75 / 100
View asset →
iron metabolism diseaseDormant
BBB
Indicative · Phase 4
73 / 100
View asset →
beta thalassemiaDormant
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →